Terns Pharmaceuticals
Uday Devanaboyina holds a Ph.D. in Toxicology from the University of Kentucky, along with a BVSc and MVSc in Veterinary Medicine from the College of Veterinary Sciences, AP Agric. University in Tirupathi, India. Uday is currently the Director of Toxicology at Terns Pharmaceuticals and has previously served as a Senior Principal Scientist at Merck, as well as an R&D Scientist in Nonclinical Drug Development at Corium, Inc. Additionally, Uday has experience as a Senior Scientist in Toxicology at Southern Research and has worked as a Consultant in Toxicology for Nonclinical Drug Safety.
Terns Pharmaceuticals
An emerging global leader in the development of molecularly-targeted drugs and combination therapies to treat liver diseases and liver cancer.